Unknown

Dataset Information

0

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation.

ABSTRACT: CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter's transformation (RT). One patient with RT never received therapy. The cytokine release syndrome rate was 87.5% (12.5% grade ≥3). Neurotoxicity was not observed in any patient. All patients experienced absolute B-cell aplasia, and seven (87.5%) responded to therapy. With a median follow-up of 5.6 months, two patients with RT experienced a CD19-negative relapse. In conclusion, ARI-0001 cell therapy was feasible, safe, and effective in patients with high-risk CLL or RT.

SUBMITTER: Ortiz-Maldonado V 

PROVIDER: S-EPMC8841853 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter's transformation (RT). One patient with RT never received therapy. The cytokine release syndrome rate was 87.5% (12.5% grade ≥3). Neurotoxicity was not observed in any patient. All patients experienced absolute B-cell aplasia, and seven (87.5%) responded to therapy. W  ...[more]

Similar Datasets

Unknown Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.
| S-EPMC8341347 | biostudies-literature
Unknown Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.
| S-EPMC9823097 | biostudies-literature
Unknown Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
| S-EPMC8671976 | biostudies-literature
Unknown Cellular Therapies in Chronic Lymphocytic Leukemia and Richter's Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant.
| S-EPMC10046903 | biostudies-literature
Unknown CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory Malignancies.
| S-EPMC7854276 | biostudies-literature
Unknown Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
| S-EPMC6443055 | biostudies-literature
Unknown Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.
| S-EPMC4040914 | biostudies-literature
Genomics Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome (RS)
| PRJNA736119 | ENA
Genomics Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome (RS)
| PRJNA736118 | ENA
Unknown Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
| S-EPMC10155825 | biostudies-literature